High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.
about
Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastasesSurgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastasesProphylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patientsCombining Carcinoembryonic Antigen and Platelet to Lymphocyte Ratio to Predict Brain Metastasis of Resected Lung Adenocarcinoma PatientsBrain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival.Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastasesDevelopment of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib.HER2-positive, trastuzumab-resistant metastatic esophageal cancer presenting with brain metastasis after durable response to dual HER2 blockade: a case report.Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinomaOutcome of surgical resection for brain metastases and radical treatment of the primary tumor in Chinese non-small-cell lung cancer patientsEvolution of multidisciplinary brain metastasis management: case study and literature reviewPrognostic factors in patients with postoperative brain recurrence from completely resected non-small cell lung cancer.HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumorsRisk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancerRisk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutationPrognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study.Lung cancer prognosis before and after recurrence in a population-based settingThe impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutations.EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patientsImmunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinomaClinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors.Elevated phospho-S6 expression is associated with metastasis in adenocarcinoma of the lung.Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer.Prophylactic cranial irradiation: recent outcomes and innovations.Immunotherapy and targeted therapy in brain metastases: emerging options in precision medicine.The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer.Molecular subtyping of brain metastases and implications for therapy.Brain metastases in patients with non-small cell lung cancer: the role of mutated-EGFRs with an exon 19 deletion or L858R point mutation in cancer cell dissemination.Palliative treatment efficacy of glucose inhibition combined with chemotherapy for non-small cell lung cancer with widespread bone and brain metastases: A case report.Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.Brain metastases after definitive concurrent chemoradiotherapy in patients with stage III lung adenocarcinoma: carcinoembryonic antigen as a potential predictive factor.Brain, the last fortress of sarcoma: similar dismal outcome but discrepancy of timing of brain metastasis in bone and soft tissue sarcoma.Comparative analysis of survival, treatment, cost and resource use among patients newly diagnosed with brain metastasis by initial primary cancer.[The evaluation of pneumonectomy and bronchoplasty lobectomy in the treatment of non-small cell lung cancer: a report of 64 cases].Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion.Prophylactic Cranial Irradiation in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS).Contemporary Review of the Management of Brain Metastasis with Radiation
P2860
Q24198129-88875EBB-8837-4A0D-87F1-7323EFE0E8B8Q24235688-617D49CE-98AC-42F1-887D-6E0D62E9A6B6Q33389562-528145EF-2738-42DA-93AD-2CEC53E3486AQ33794912-149235C2-0FCB-49F6-A410-2A29B227A836Q33831950-C32BEB2E-4C51-49BE-BEC5-983144080C18Q33958338-FE1022B8-CFF3-417F-92D0-148C18E19ABCQ34393558-96A1BBBD-1995-4D80-BC11-4625099C2146Q34484252-28A8A65E-ACB2-428A-AA33-3D36EB6A36BCQ34666837-C62DD98B-C888-4C15-BA0B-2F226550096AQ34666843-095F03A4-C47A-490C-B157-E92128B255C3Q35034753-975CEF9F-CCFE-4906-9FFC-B9D15F75DD99Q35524023-15B8642B-E263-40B1-9869-D0ACF400B26EQ35652704-B303E000-C673-4831-AF3C-8CCD14528C80Q35663536-7D5429AB-3555-46CF-B3E6-1437DDEAEC87Q36025680-B492B7B8-7947-4722-A72C-2F7E7CE9297BQ36198417-B66F77CE-2524-488C-B700-27B76431C0E9Q36575287-332EDCBB-62A6-4139-A8A8-362869B7003AQ36614079-D6E53BFF-A5CE-4ABA-818D-3B6A0EBC694EQ36817059-C767128C-E6F9-4859-A6F9-1F2B5BA13DDAQ36927984-6594DD82-00BB-47E9-9522-89A0819B8451Q36977414-1A88B93C-391C-4C5F-8630-0E82A42291A8Q37003601-E39C71AA-04EE-4AF6-BCCC-83B697FA9875Q37014649-6C7104A9-4379-46E2-9361-7E93D9D23B9DQ37038176-2297BE4B-C4A7-4C14-9661-5A97F7465B39Q38067307-B86B4162-EDC8-459E-9EAA-E5D5C9DC458DQ38233180-E9F57099-5E96-42D0-89D5-72937B93C691Q38829087-2F267962-2B8E-4A53-A280-824EC3C4A229Q39043850-7E1DE6BB-5ADE-405D-BB93-BD2DDC4E7951Q39373956-FCDFB634-D875-4784-A502-FF1046FB3252Q41593193-FFD88299-6B24-4A4B-99C0-7AD2533EB2C8Q47141024-FF5B866B-4F78-435D-BFA4-03B70EF57FF0Q48409755-FCFEF723-9533-4BF9-8DAA-B10F1BFB7B3DQ48667469-70B5FB92-79B2-4C19-A75A-ABF3CB967010Q48837777-F71026BD-4D0E-4509-9CF4-3654C74E16DDQ51241214-26BEE704-5C1C-4AA7-8D9D-890560F71D36Q53271315-9D850A26-5885-402B-9D4A-5B2AF4F3DE4EQ54962187-AF87F13C-DFBD-40DF-9B07-C9721EFFD706Q54974208-8AC49C08-5C54-4D5A-8FF8-692742E02326Q55236003-C1A42E89-0510-4B70-B6A5-591FD0394AB8Q59103143-1375D785-D5D6-4437-B586-551B6EFDCAEB
P2860
High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
High risk of brain metastases ...... , chemotherapy, and radiation.
@ast
High risk of brain metastases ...... , chemotherapy, and radiation.
@en
type
label
High risk of brain metastases ...... , chemotherapy, and radiation.
@ast
High risk of brain metastases ...... , chemotherapy, and radiation.
@en
prefLabel
High risk of brain metastases ...... , chemotherapy, and radiation.
@ast
High risk of brain metastases ...... , chemotherapy, and radiation.
@en
P2093
P356
P1476
High risk of brain metastases ...... , chemotherapy, and radiation.
@en
P2093
Arthur Skarin
Beow Yong Yeap
Elizabeth H Baldini
Harvey J Mamon
Jason Reblando
Jeanne M Lukanich
Michael T Jaklitsch
Raphael Bueno
Sarah Shrager
Steven Mentzer
P304
P356
10.1200/JCO.2005.04.123
P407
P577
2005-03-01T00:00:00Z